Showing 1 - 10 of 22
Persistent link: https://www.econbiz.de/10001782488
Persistent link: https://www.econbiz.de/10003801344
In this paper, the impact of increased consumer information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in information is likely to reduce the price of brand name pharmaceuticals, while the results...
Persistent link: https://www.econbiz.de/10005652004
This paper analyses the factors that determine entry into the Swedish pharmaceuticals market. The analysis is based on panel data for 22 different substances covering the years 1972 to 1996. The results show that profit opportunities in a particular market have a positive impact on entry. In...
Persistent link: https://www.econbiz.de/10005652023
Persistent link: https://www.econbiz.de/10001573283
Persistent link: https://www.econbiz.de/10001573290
Persistent link: https://www.econbiz.de/10001612905
Persistent link: https://www.econbiz.de/10001811327
The paper empirically studies whether pharmaceutical firms use advertising as a signal for high quality drugs. A multiple random effects count data hurdle model is specified and a simulated maximum likelihood estimation approach is developed and utilized in the empirical analysis
Persistent link: https://www.econbiz.de/10014206723
This paper analyses how market shares for brand name drugs are affected by generic competition. The analysis is based on micro data for twelve different original drugs, which are all subject to generic competition. For five of these drugs, we find that the price of the original relative to the...
Persistent link: https://www.econbiz.de/10005649306